Aardvark Therapeutics, Inc. cotiza a 4.21 USD y tiene una capitalización bursátil de $92M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | — | $-0.99 | $-0.81 |
| Estimado | $-0.75 | $-0.88 | $-0.91 | $-0.83 |
| Sorpresa | — | — | -8.8% | +2.4% |
| Métrica | AARD | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -54.0% | -40.4% | -13.6% |
| ROA | -49.1% | -32.0% | -17.1% |
| Current Ratio | 10.61 | 2.84 | +7.77 |
| Debt / Equity | — | 0.28 | — |